Upload File

pembrolizumab vrs. ipilimumab

21
Dr. Hugo Castro Dr, Julio Herol de León Guatemala, 28 agosto de 2015

Upload: julio-herol-de-leon

Post on 07-Feb-2017

226 views

Category:

Health & Medicine


0 download

Report

TRANSCRIPT

Page 1: Pembrolizumab vrs. ipilimumab

Dr. Hugo CastroDr, Julio Herol de León

Guatemala, 28 agosto de 2015

Page 2: Pembrolizumab vrs. ipilimumab
Page 3: Pembrolizumab vrs. ipilimumab
Page 4: Pembrolizumab vrs. ipilimumab
Page 5: Pembrolizumab vrs. ipilimumab

Métodos

• Inclusión

• Exclusión

Page 6: Pembrolizumab vrs. ipilimumab
Page 7: Pembrolizumab vrs. ipilimumab
Page 8: Pembrolizumab vrs. ipilimumab
Page 9: Pembrolizumab vrs. ipilimumab
Page 10: Pembrolizumab vrs. ipilimumab
Page 11: Pembrolizumab vrs. ipilimumab
Page 12: Pembrolizumab vrs. ipilimumab
Page 13: Pembrolizumab vrs. ipilimumab
Page 14: Pembrolizumab vrs. ipilimumab
Page 15: Pembrolizumab vrs. ipilimumab
Page 16: Pembrolizumab vrs. ipilimumab
Page 17: Pembrolizumab vrs. ipilimumab
Page 18: Pembrolizumab vrs. ipilimumab
Page 19: Pembrolizumab vrs. ipilimumab
Page 20: Pembrolizumab vrs. ipilimumab
Page 21: Pembrolizumab vrs. ipilimumab

Ipilimumab-induced renal granulomatous arteritis: a case

Pembrolizumab for untreated metastatic or unresectable

Phase Ib Dose-Finding Study of Axitinib Plus Pembrolizumab ... · Pembrolizumab in Treatment-Naïve Patients ... and tolerability of axitinib plus pembrolizumab in treatment-naïve

Pembrolizumab microgravity crystallization experimentation

Simulación en robótica con VirtualRobot - Monkers.net Introduccion VRS.pdf · VRS LOADER 9 5. VRS TEACHPENDANT 12 6. VRS TRACECONTROL 19 7. VRS IOCONNECTION 20 8. VRS PARTHANDLING

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

VRS annual status report - Virginia JLARCjlarc.virginia.gov › pdfs › oversight › VRS › 2018_VRS-Pres.pdf · 8/99: VRS Mortgage & VRS Corporate 7/02: VRS Agency 7/15: Launch

Abbreviated Title: CAPOX Pembrolizumab in BTC

AVIS ECONOMIQUE Keytruda (pembrolizumab )

Pembrolizumab - G-BA

Are patients overdosed with the present recommendations?...N Engl J Med. 2015;372:2521–32. Ribas A, et al. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory

YERVOY, INN- ipilimumab

Pembrolizumab in advanced melanoma

The Changing Field of Melanoma: Ipilimumab

YERVOY FR PM - bms.com · PDF fileMonographie de YERVOY* (ipilimumab pour injection) Page 1 de 60 MONOGRAPHIE PrYERVOYMD Ipilimumab pour injection Perfusion intraveineuse d'ipilimumab

Pembrolizumab vs Quimioterapia Keynote 024

> STARPOINT - RUD Ketten€¦ · VRS-F mit Schlüssel metrisch - VRS ohne Schlüssel metrisch / metric (VRS-F) with and without STAR KEY (VRS) / Filetage métrique avec clé (VRS-F)

424 Original Article Pembrolizumab combined with

Ipilimumab and BRAF inhibitors cutaneous toxicity

Single Technology Appraisal Pembrolizumab with axitinib

YOUR YERVOY ® (ipilimumab) ACTION PLAN

AnEconomicEvaluationofPembrolizumabVersusOtherAdjuvant … · Pembrolizumab Observation Ipilimumab RF → LR Gompertz Shape = 0.0252 Rate = 0.0040 Gompertz Shape = 0.0184 Rate = 0.0052

Pembrolizumab reactivates pulmonary granulomatosis

Malignant melanoma treated with pembrolizumab during

18/09/2016 - ae2bm.orgae2bm.org/wp-content/uploads/2016/09/Lessor-des-anticorps... · Yervoy®, ipilimumab, #CTLA4 Keytruda®, pembrolizumab, #PD1 Opdivo ®, nivolumab, #PD1 … Immunoconjugués

YOUR KEYTRUDA® (pembrolizumab) ACTION PLAN

Keytruda, INN pembrolizumab

Ipilimumab Causing Autoimmune Hypophysitis : A Case Reportriverapublications.com/assets/files/pdf_files/ipilimumab-causing-autoimmune...ipilimumab - associated hypopituitarism but

PLANUNGSHILFEN SERIE VRS EN | VRS C

VRS Oversight Report - December 2015 - JLARCjlarc.virginia.gov/pdfs/reports/Rpt480.pdf · VRS Oversight Report 2 VRS fast facts . Source: VRS 2015 annual report and investment department

INLYTA (axitinib) + pembrolizumab THERAPY MANAGEMENT …

Az első, túlélést meghosszabbító immunterápia, az ipilimumab … · 2020. 8. 10. · Az első, túlélést meghosszabbító immunterápia, az ipilimumab klinikai és immunpatológiai

Major Changes in Systemic Therapy for Advanced …...Melanoma •173 patients with melanoma that progressed after ≥2 doses of ipilimumab •Allocated randomly to pembrolizumab IV

E.R. Squibb & Sons, L.L.C. YERVOY- ipilimumab injection

Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab … · 2017-04-10 · Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab